Medellada, John Mike .
HRN: 24-58-44 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFUROXIME 750MG (VIAL)
02/19/2024
02/26/2024
IV
410mg
Q8
UTI; Amoebiasis
Waiting Final Action
02/20/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/20/2024
02/27/2024
ORAL
6ml
Q8
Age
Waiting Final Action